| This article has been cited by |
| 1 | Advances in pharmacovigilance in India: Role of mobile application | |
| Rajpushpa Labh,Sachin Gupta,Rachna Gupta |
| Indian Journal of Medical Specialities.2020;11(3)124 |
| [DOI] |
|
| 2 | Pharmacovigilance in low- and middle-income countries: A review with particular focus on Africa | |
| Ronald Kiguba,Sten Olsson,Catriona Waitt |
| British Journal of Clinical Pharmacology.2023;89(2)491 |
| [DOI] |
|
| 3 | A Mobile App Leveraging Citizenship Engagement to Perform Anonymized Longitudinal Studies in the Context of COVID-19 Adverse Drug Reaction Monitoring: Development and Usability Study | |
| Marzia Di Filippo,Alessandro Avellone,Michael Belingheri,Maria Emilia Paladino,Michele Augusto Riva,Antonella Zambon,Dario Pescini |
| JMIR Human Factors.2022;9(4)e38701 |
| [DOI] |
|
| 4 | Adverse drug reaction reporting via mobile applications: A narrative review | |
| Dario Leskur,Josko Bozic,Doris Rusic,Ana Seselja Perisin,Tin Cohadzic,Shelly Pranic,Darko Modun,Josipa Bukic |
| International Journal of Medical Informatics.2022;168(4)104895 |
| [DOI] |
|
| 5 | Impact of educational intervention and reinforcement on adverse drug reporting by nursing students: A prospective follow up study | |
| Manisha Bisht,Puneet Dhamija,Bhomik Goel,Vasantha Kalyani,ShailendraS Handu |
| Journal of Public Health and Primary Care.2020;1(1)36 |
| [DOI] |
|
| 6 | Impact of educational intervention and reinforcement on adverse drug reporting by nursing students: A prospective follow up study | |
| Elena E. Chupandina,Maria S. Kurolap,Elena V. Boldyreva,Alexandra V. Kuzyomkina,Olga L. Sviridova |
| Journal of Public Health and Primary Care.2022;1(1)305 |
| [DOI] |
|
| 7 | Thai stakeholders’ awareness and perceptions of the patient adverse event reporting system for herbal medicines: a qualitative study | |
| Wiwan Worakunphanich,Wimon Suwankesawong,Sitaporn Youngkong,Montarat Thavorncharoensap,Claire Anderson,Li Shean Toh |
| International Journal of Clinical Pharmacy.2023;45(2)491 |
| [DOI] |
|
| 8 | Evolution of adverse drug reactions reporting systems: paper based to software based | |
| M. T. Madhushika,T. P. Weerarathna,P. L. G. C. Liyanage,S. S. Jayasinghe |
| European Journal of Clinical Pharmacology.2022;78(9)1385 |
| [DOI] |
|
| 9 | Smartphone-based mobile applications for adverse drug reactions reporting: global status and country experience | |
| Ayako Fukushima,Noha Iessa,Madhava Ram Balakrishnan,Shanthi Narayan Pal |
| BMC Medical Informatics and Decision Making.2022;22(1)1385 |
| [DOI] |
|
| 10 | Mobile apps for quick adverse drug reaction report: A scoping review | |
| Edna Ribeiro Parracha,Ana Margarida Advinha,Manuel José Lopes,Sofia Oliveira-Martins |
| Pharmacoepidemiology and Drug Safety.2023;32(1)19 |
| [DOI] |
|
| 11 | Adverse event reporting tools and regulatory measures in India through outcome of Pharmacovigilance Programme of India | |
| Jai Prakash,Raghav Sachdeva,TaraniPrakash Shrivastava,CV Jayachandran,Aseem Sahu |
| Indian Journal of Pharmacology.2021;53(2)143 |
| [DOI] |
|
| 12 | Effectiveness of the Med Safety mobile application in improving adverse drug reaction reporting by healthcare professionals in Uganda: a protocol for a pragmatic cluster-randomised controlled trial | |
| Ronald Kiguba,Norah Mwebaza,Ronald Ssenyonga,Helen Byomire Ndagije,Victoria Nambasa,Cordelia Katureebe,Kenneth Katumba,Phil Tregunno,Kendal Harrison,Charles Karamagi,Kathryn A Scott,Munir Pirmohamed |
| BMJ Open.2022;12(7)e061725 |
| [DOI] |
|
